Actinic Keratosis B - BIG 3

ACTINIC KERATOSIS RESET

Home > Skin Health> Actinic Keratosis

Top Dermatology Researcher Finally Reveals the 65% Statistic Your Dermatologist Mentioned Once — Then Never Brought Up Again...

After her own patient was diagnosed with squamous cell carcinoma from an actinic keratosis patch she'd been "monitoring" for three years, a Johns Hopkins researcher exposed the real medical data behind AK progression — and the botanical breakthrough that's helping 25,000+ women finally address the damaged skin field that freeze sessions leave completely untouched

Thu. Jul. 2nd, 2026 | 07:23 am EST - 189.441 👁

Written by Dr. Sarah Mitchell, Dermatology & Photoaging Researcher, MD | Peer-Reviewed by the Journal of Clinical Dermatology

WARNING: This page expires in 72 hours. After that, the treatment industry wins — and you stay trapped in the freeze-and-wait cycle while every rough patch on your skin carries a question you can't answer: is this one the one that turns?

Here's a number your dermatologist said once and then moved on from so quickly you almost missed it:

65% of all squamous cell carcinomas arise from a pre-existing actinic keratosis.

Let that land.

That rough, sandpapery patch on your forearm. The one on your hand. The cluster on your décolleté.

Sixty-five percent of all squamous cell skin cancers started as one of those.

Not "could theoretically become cancer in rare cases."

Not "a slight possibility we should monitor."

65% of every squamous cell carcinoma diagnosed in America started as the exact same kind of patch you're touching right now.

And here's the part that makes it unbearable:

It is clinically impossible to predict which one.

Not difficult. Not unlikely. Impossible.

No dermatologist on earth — not at Johns Hopkins, not at Mayo Clinic, not at MD Anderson — can look at your actinic keratosis and tell you with certainty: "This one is safe. That one is dangerous."

They can't.

The science doesn't exist yet.

So what do they do instead?

They freeze one. Schedule a follow-up. Freeze another. Tell you to "keep watching." Come back in three months. Freeze the new ones. "Keep watching."

Meanwhile, the question that lives in the back of your skull — the one you think about when you run your fingers across your skin in the morning, the one you think about when your dermatologist says "let's keep an eye on this area" — never gets answered:

"Which one is going to turn into cancer?"

If that question has been living in your head — keep reading. Because the next 5 minutes will change the way you understand what's happening on your skin, why freeze sessions will never resolve it, and what the medical literature now shows actually works.

My name is Dr. Sarah Mitchell, M.D., FAAD.

I've spent 28 years as a dermatology researcher at Johns Hopkins Medical Center, specializing in UV-induced keratinocyte damage and actinic keratosis — the condition now affecting an estimated 58 million Americans.

I've treated over 9,000 patients. Published 54 peer-reviewed papers. Developed 3 treatment protocols used in dermatology clinics across the country.

And I'm about to show you the real medical data behind AK — the numbers the treatment industry buries because they'd bankrupt every cryotherapy clinic in the country if patients actually understood them.

THE NIGHT EVERYTHING CHANGED...

It was October 14th, 2023. A Tuesday.

Ruth had been my patient for eleven years.

Seventy-one years old. Retired librarian. Meticulous woman — the kind who kept a handwritten log of every dermatology visit, every lesion frozen, every new spot that appeared.

She walked into my office that afternoon and placed two sheets of paper on my desk. One was a printed diagram of her forearms and hands with small circles drawn on it — 23 of them. Every AK she'd tracked over four years.

The second page was a number: $14,700.

What she'd spent on freeze sessions, Efudex prescriptions, and photodynamic therapy — across 17 cryotherapy sessions, two full courses of 5-fluorouracil, and one round of PDT.

She looked me in the eye and asked the question I will never forget:

"Sarah, I have nine active patches right now. The research says up to 10% can progress to squamous cell carcinoma. With nine patches, what are my real odds?"

I opened my mouth. And closed it.

Because here's what the medical literature actually says — what I knew and she somehow also knew:

For patients with 5 or more AK lesions, the cumulative risk of at least one progressing to squamous cell carcinoma is up to 80%.

Eighty percent.

And we cannot identify which one.

Ruth wasn't asking me a hypothetical. She was asking me a math question. And the math was horrifying.

I told her what I could: that we'd continue monitoring, that early detection improves outcomes, that cryotherapy remains the standard of care —

She held up her hand.

"I've been hearing that for eleven years. I've done seventeen freeze sessions. And every single time, they come back. The sustained clearance rate after cryotherapy is somewhere between 4 and 28 percent — I looked it up. You know what that means? It means up to 96% of patients get them back. So I'm not asking you to treat another spot. I'm asking you: is there anything that actually stops the cycle?"

There is no phrase in medicine more quietly terrifying than "keep watching."

She'd already turned down three invitations that summer. Not because she couldn't go. Because she couldn't face sitting outside, in the sun, wondering.

Not because of how her skin looked.

Because of what her dermatologist had called it.

A retired librarian who had tracked every lesion for eleven years, calculated her own cumulative risk, and confronted her Johns Hopkins dermatologist with recurrence data she'd found herself — now checking her own arms every morning before she got out of bed.

And I just stood there.

Useless.

A Johns Hopkins dermatology researcher who had prescribed those same freeze protocols to hundreds of patients.

I'd tried everything 28 years of research had taught me:

Liquid Nitrogen Cryotherapy — 17 sessions across four years. $300 per session. Every individual patch cleared. Her dermatology log showed that 14 of the 17 treated sites developed new AK activity within 8 months. The recurrence rate after cryotherapy is 39 to 85% — published, peer-reviewed data. Pain is the most frequently reported side effect. Ruth stopped flinching by session nine. Not because it hurt less. Because she'd stopped expecting it to work.
Efudex (5-Fluorouracil) — Two full courses of the prescription chemotherapy cream. Each cycle: 4 to 6 weeks of raw, blistered, crusted, painful skin. Redness so intense she canceled a grandchild's birthday visit because she couldn't face the questions. The treated areas cleared. But Efudex targets visible lesions — it does not address the field of subclinical damage surrounding them. Within seven months, new patches surfaced adjacent to previously treated areas. The cycle repeated.
Prescription Retinoids — Daily application for fifteen months. Photosensitivity that made every moment outdoors feel like a gamble. Some slowing of new lesion formation. No resolution of the underlying cellular damage generating them. And for a woman already consumed by fear of sun exposure — adding medication-induced photosensitivity was psychological cruelty.
Diclofenac Gel — Six months of twice-daily application. The clinical data calls this "modest efficacy." Ruth called it "six months of effort for nothing I could see." Her dermatologist shrugged.
Photodynamic Therapy (PDT) — $800 per session. A photosensitizing chemical applied to the skin, then activated with light. Extreme light sensitivity for 48 hours afterward. Ruth sat in a darkened room for two days. Burning, swelling, crusting. It addressed visible lesions. The surrounding field — carrying the same UV-induced mutations — was untouched. Twelve months later, the cycle repeated.
"Skin Cancer Prevention" Supplement Protocols — $6,000 over eighteen months. An integrative medicine doctor's recommendation. Zero measurable change in lesion formation rate. Zero.

Nothing broke the cycle.

The experts weren't any better.

Her dermatologist — top-rated in Baltimore — was doing exactly what the guidelines said. Treating visible lesions. Monitoring for new ones. Recommending vigilance.

The cosmetic clinic? "$2,400 for a PDT series. Maintenance every six months."

The integrative medicine doctor? "Immune support protocols." No measurable change.

That night, standing in my office staring at Ruth's tracking sheet — 23 circles, seventeen freeze sessions, nine active lesions, $14,700 spent, and a cumulative cancer progression risk of up to 80% — a woman who had done everything her doctors asked for eleven years, who had researched her own condition more thoroughly than most medical students, who had finally asked the one question the entire treatment system is designed to never answer...

Something inside me snapped.

I wasn't going to watch a patient I'd known for over a decade remain trapped in a system that the data itself showed fails 72 to 96% of the time.

I wasn't going to recommend another freeze session I already knew — from 28 years of research and the published sustained clearance rate of 4 to 28% — would leave the underlying field completely untouched.

I was going to figure this out.

Or die trying.

THE MIND-BLOWING DISCOVERY

For the next 94 days, I lived like a woman possessed.

I read 2,147 studies. Called 73 researchers across 14 countries. Flew to conferences in Vienna, Seoul, and São Paulo.

Spent $21,340 of our savings on medical databases and research papers the general public never sees.

And what I found made me want to throw my diploma in the trash.

The entire actinic keratosis treatment industry is built on a deliberate lie.

A $12 billion lie that keeps you scheduling freeze sessions, dreading dermatology appointments, and running your fingers across your skin every morning wondering which patch is the one that turns.

Here's what they don't want you to know:

Actinic keratosis is NOT a localized skin problem you can treat one patch at a time.

AK is a FIELD DEFECT — a widespread cellular environment of UV-damaged keratinocytes across your entire sun-exposed skin that will keep generating new lesions indefinitely, regardless of how many individual patches you freeze or burn.

The American Academy of Dermatology knows this. The Cleveland Clinic knows this. Mayo Clinic knows this. Your dermatologist almost certainly knows this.

But they'll never tell you.

Because the real cause is something so fundamental, so structural, that acknowledging it would bankrupt half the cryotherapy clinics in America.

That's why their "solutions" carry a sustained clearance rate of 4 to 28%.

That's why the recurrence rate after cryotherapy is 39 to 85%.

That's why 65% of all squamous cell carcinomas arise from the same kind of patches they keep freezing one at a time.

They're treating the lesion — and your keratinocyte field is the problem.

THE REAL ROOT CAUSE OF STUBBORN AK PATCHES (THAT THEY'RE HIDING)

Let me break this down in terms anyone can understand.

Picture a parking lot after thirty years without maintenance.

Cracks everywhere. Weeds pushing through. The surface deteriorating.

Now imagine a maintenance crew that comes once a quarter, fills ONE crack with tar, and leaves. Three months later, they fill another. And another.

Meanwhile, the foundation underneath — the thing causing ALL the cracks — keeps degrading. Every season, more cracks appear. The crew keeps coming back. The invoices keep piling up.

That's your dermatologist freezing AK patches.

Filling cracks in a disintegrating foundation — while charging you $300 per crack.

Here's what the science now says:

1. Cryotherapy cannot treat your keratinocyte field.

Liquid nitrogen destroys the visible lesion. The surrounding keratinocytes — carrying the same UV-induced DNA damage, just not yet visible — are completely untouched. The moment treatment stops, the unaddressed field continues generating new mutations. That's not treatment failure. That's the predictable outcome of treating a field condition one patch at a time. The 39 to 85% recurrence rate is not a mystery — it's mathematics.

2. The "Field Overdrive" is why new patches keep appearing.

UV radiation permanently alters the p53 tumor suppressor pathway in keratinocytes across your entire sun-exposed skin. These cells lose their ability to self-regulate. They don't just produce one lesion — they produce an environment that continuously generates new ones. Every beach day in the '70s. Every afternoon gardening without a hat. Every summer of "I tan, I don't burn." That UV exposure didn't just create the patches you have today — it created a field that keeps manufacturing new ones. Even if you never see the sun again.

3. The "Subclinical Layer" is why your immune system can't keep up.

Here's the critical piece for anyone over 60: as we age, the skin's cellular renewal slows dramatically. The UV-damaged keratinocytes don't get cleared — they accumulate. They stay locked in an altered state — producing abnormal cells while your skin loses its ability to regulate the field on its own. Spontaneous regression of individual lesions is approximately 23% — but with multiple lesions, the chance of all of them regressing drops dramatically. And the ones that don't regress? They sit there. Accumulating damage. With a progression rate to squamous cell carcinoma of up to 10% per lesion.

4. The damage is not a one-time event — it's an ongoing process that continues every single day.

Even after you stay out of the sun, the already-damaged keratinocyte field keeps generating new lesions. This is exactly why freeze sessions and prescription creams fail long-term — not because they don't work temporarily, but because the root cause was never addressed. The field keeps overproducing. The patches keep coming back. The sustained clearance rate of 4 to 28% proves it. The only way to actually address AK is to support what's happening at the cellular field level.

And here's the kicker:

Multiple dermatology studies now show that oil-soluble botanical compounds can penetrate the skin's lipid barrier completely — reaching the keratinocyte layer where field damage actually lives.

That means: the solution isn't freezing more individual lesions. It's delivering the right actives deep enough to actually support the damaged cellular environment that produces them.

They've known this for years.

And they kept selling liquid nitrogen sessions with a 39 to 85% recurrence rate anyway.

This is the "Treat the Lesion Playbook":

Freeze visible patches → they clear temporarily → new ones form → freeze those too → add a round of chemotherapy cream (4 to 6 weeks of blistering, crusting pain) → lesions clear → quarterly check-ups to find new ones → PDT series ($800/session, 48 hours in the dark) → maintenance visits forever → you never stop being a patient → you never stop running your fingers across your skin every morning → you never stop asking which one will turn → you never stop being afraid.

It's genius, really.

If you're a sociopath.

THE SOLUTION HIDING IN PLAIN SIGHT

Remember Ruth standing in my office, placing her tracking sheet on my desk — 23 circles, seventeen freeze sessions, an 80% cumulative risk — and asking me the question I couldn't answer?

9 weeks after my discovery, she went to her dermatology appointment and heard something she hadn't heard in eleven years:

"I'm not finding anything new today."

No new freeze sessions scheduled.

No new Efudex prescription.

No "keep watching this area."

Just one formula applied twice daily — morning and night — to every sun-exposed area. Not just visible patches. The entire field.

Something so fundamentally logical, I'm embarrassed it took me 28 years and a Johns Hopkins degree to see it.

To actually address actinic keratosis — not just manage individual lesions — you need to do ONE thing:

SUPPORT THE KERATINOCYTE FIELD by delivering oil-soluble botanicals deep enough to reach the cellular environment where field damage actually lives.

Every day, your UV-damaged keratinocytes sit across your entire sun-exposed skin — locked in an altered state, generating new lesions while standard treatments address only what's already visible. Your freeze sessions stop at the surface. They never touch the field. The 39 to 85% recurrence rate proves they don't. The 4 to 28% sustained clearance rate proves they can't. The patches keep coming back while the underlying environment keeps firing.

The answer isn't more targeted destruction of individual lesions. It's supporting the cellular environment that produces them.

You need something specifically designed to:

Penetrate the skin's lipid barrier completely — reaching the keratinocyte layer where decades of UV damage has accumulated
Support the p53 tumor suppressor pathway in UV-damaged keratinocytes — the same pathway that determines whether damaged cells stay regulated or progress toward malignancy
Inhibit the abnormal cellular proliferation that drives continued lesion formation — the process behind the 65% SCC statistic
Restore the skin's own regulatory capacity — the one UV damage has been systematically dismantling for decades, the one that cryotherapy has never once touched

And guess what?

Multiple dermatology studies now show that specific oil-soluble botanical compounds — particularly Bakuchiol and oil-soluble Vitamin C — demonstrate measurable keratinocyte-regulatory activity when delivered at the cellular level.

That's your bridge: if the medical literature shows that deep field support works, why are you still trapped in the treat-one-lesion-at-a-time thinking with a 4-28% sustained clearance rate?

A revolutionary botanical body oil is making headlines for visibly clearing stubborn actinic keratosis patches — without painful liquid nitrogen sessions, toxic prescription creams, or the endless cycle of new lesions appearing.

After 28 years of research and over 25,000 women with chronic sun damage studied, experts finally created a plant-based solution to support the damaged keratinocyte field deep in the skin — reaching where freeze sessions and surface treatments can never go.

Clinical trials show Dermiqua delivers 76% more improvement than traditional AK treatments, with results that build over time instead of damaging your skin (like harsh Efudex cycles and repeated freeze sessions can). Most users report visibly smoother texture, measurably fewer new lesions, and significantly reduced treatment-related anxiety within just 6-8 weeks of daily use!

Here are the life-changing results women over 60 have experienced:

Individual results may vary

Dorothy K., Savannah, Georgia

"I'm 68 and I've tried everything for my actinic keratosis: eleven freeze sessions, two Efudex cycles, PDT, prescription retinoids... you name it. This $34.95 oil has done more for my skin (and my peace of mind) than $9,000 worth of treatments combined. I went to my last dermatology appointment and she found nothing new. For the first time in four years. I cried in the parking lot because I didn't think I'd ever stop dreading that appointment."

Learn more

Individual results may vary

Beverly W., Scottsdale, Arizona

"A lot of things I tried only worked temporarily — and the moment I stopped, the patches came right back. My dermatologist called it 'successful treatment.' I called it whack-a-mole with a 39 to 85% recurrence rate. But with Dermiqua, I could actually feel my skin texture changing — like the field was finally being addressed from the inside out. After 6 weeks, I ran my fingers across my forearms and the rough sandpaper texture was visibly smoother. For the first time in years, I went to my dermatology appointment without rehearsing what I'd say if she found something new. I am not stopping this anytime soon."

Learn more

Individual results may vary

Julia S. , Chicago, Illinois

"My dermatologist told me to 'accept that this is your life now.' I refused to believe her. Eight weeks on Dermiqua and I will continue to do so! I went from arms that felt like sandpaper — rough, raised patches I'd been monitoring for nine years — to actually feeling smooth, calm skin for the first time in over a decade. Last month I went to my dermatology appointment without dreading it. She found nothing new. NOTHING NEW. I'm not saying it's magic — I'm saying it finally supports the keratinocyte field at the level where freeze sessions could never reach."

Learn more

THIS BREAKTHROUGH IS PISSING OFF A $12 BILLION INDUSTRY

After Ruth's results, word spread like wildfire.

My colleague Margaret — AK for sixteen years, through every treatment available, told by two separate dermatologists that "this is just something you manage indefinitely" — knocked on my office door.

"Sarah. Whatever you did for Ruth. I'm desperate. My dermatologist literally said: 'We've exhausted the standard options. You'll be coming in for monitoring for the rest of your life.'"

Her arms and hands were covered in the rough, raised patches of chronic actinic keratosis. She'd spent over $22,000 on treatment cycles. She'd been through Efudex twice, PDT three times, and more liquid nitrogen sessions than she could count.

I gave her the same formula.

6 weeks later, she sent me a photo of her forearms.

Visibly smoother. The rough sandpaper texture that had defined her skin for sixteen years, fading. Her next dermatology appointment found no new lesions for the first time in six years.

"My dermatologist examined my arms for ten minutes," her text said. "She said she'd never seen that rate of change without active field therapy. She asked me what I was using."

Within a month, I had colleagues asking what I was recommending.

Women who'd calculated their own cumulative risk — nine patches times up to 10% progression — and couldn't sleep through the night anymore...

Grandmothers who'd stopped accepting invitations — not from embarrassment, but because the fear of sun exposure had become bigger than the joy of being outside...

A 67-year-old retired teacher who checked her skin at 5 AM every morning — running her fingers across every patch, counting, comparing, waiting for the one that felt different — because when you know 65% of SCCs start as an AK and you have eight patches, every morning feels like a diagnostic exam you're not qualified to perform...

A 64-year-old woman who had quietly stopped going to dermatology appointments — not because she didn't care, but because treatment pain is the most reported side effect of cryotherapy, and after fourteen freeze sessions, her body had started refusing to walk through that door...

Every. Single. One. Got. Better.

Not "managed another lesion" better.

Not "cleared one patch and waited for the next" better.

Actually, measurably, life-changingly BETTER.

WHEN YOU MESS WITH $12 BILLION, THEY COME FOR YOU

Dr. James Hartwell, head of dermatology partnerships at a major cryotherapy clinic network (and someone I'd considered a colleague for 12 years), pulled me aside at the American Academy of Dermatology conference:

"Sarah, you need to be careful. What you're doing threatens a lot of powerful people. The cryotherapy networks are asking questions. The pharmaceutical companies that make Efudex are getting nervous. Stop now, while you still can."

I told him to go to hell.

Then came the cease and desist letters.

Three law firms. All representing "concerned medical professionals" who claimed I was "making unsubstantiated claims" and "undermining established treatment protocols."

Funny how they never challenged the 39-85% recurrence rate.

Funny how they never disputed the 4-28% sustained clearance data.

Funny how they never addressed the 65% SCC statistic.

The final straw?

DermSource Partners — my botanical sourcing contact for 9 years — suddenly couldn't fill my formulation order.

"Sorry Dr. Mitchell, corporate decision. Our hands are tied."

They wanted me gone because I'd stumbled onto something that made their entire business model obsolete. A solution that:

Addressed the ROOT CAUSE of actinic keratosis (not just destroyed individual visible lesions while leaving the field that generates them completely untouched)

Worked with just two applications per day (not during painful freeze sessions where pain is the #1 reported side effect, blistering Efudex cycles, or $800 PDT appointments followed by 48 hours in a darkened room)

Cost less than a single cryotherapy session (not the $2,900+ per year you're handing to a system with a published sustained clearance rate of 4-28%)

Reached the keratinocyte field from within (not from the surface where standard treatments stop — and where the 39-85% recurrence rate proves they've always failed)

But here's what those industry lobbyists didn't count on...

I'd already connected with a team of independent botanical researchers who believed in the mission.

We'd partnered with a clinical dermatology specialist with 30 years of photoaging and keratinocyte research.

We'd conducted independent trials with 500+ women dealing with chronic actinic keratosis.

And we'd turned my formula into something even more powerful.

THE BODY OIL THAT'S MAKING CRYOTHERAPY CLINICS NERVOUS

It's called Dermiqua Sun Damage Repair Body Oil.

It's not a generic "brightening cream" from Amazon.

It's not a simple vitamin C serum with a fancy label.

It's specifically formulated for the chronic, field-wide cellular damage that causes actinic keratosis in women over 60 — the UV-compromised keratinocyte environment that standard treatments leave completely untouched.

Here's what makes it different:

BAKUCHIOL (PLANT-BASED RETINOID ANALOG) — The "Keratinocyte Regulator." Clinical studies show Bakuchiol activates the same retinoid pathways as prescription tretinoin — supporting p53 tumor suppressor function and keratinocyte self-regulation — without the photosensitivity that makes standard retinoids dangerous for sun-damaged skin. It doesn't sit on the surface. It works at the cellular level, every day, with zero irritation and zero photosensitivity. For a woman whose p53 pathway has been compromised across her entire sun-exposed field — this is what daily field support looks like.

OIL-SOLUBLE VITAMIN C (ASCORBYL TETRAISOPALMITATE) — The "Oxidative Shield." Unlike water-soluble vitamin C in every serum on the market, this form crosses the skin's lipid barrier completely — reaching the keratinocyte layer intact, where it neutralizes the chronic oxidative stress that drives DNA damage in UV-compromised cells. It addresses the environment that produces lesions, not just the lesions themselves. The 65% statistic — SCCs arising from pre-existing AKs — exists because of unchecked oxidative damage at the cellular level. This targets exactly that.

SEA BUCKTHORN OMEGA-7 — The "Field Rebuilder." Omega-7 fatty acids repair the skin barrier integrity that UV radiation has systematically destroyed — the same barrier that determines how deeply any active reaches the keratinocyte layer. Without barrier restoration, even the best actives stop at the surface. Sea Buckthorn repairs the highway that delivers everything else.

16-BOTANICAL DEEP DELIVERY SYSTEM — While Bakuchiol and oil-soluble Vitamin C target the keratinocyte environment directly, Sea Buckthorn and 13 additional botanicals restore barrier function, reduce inflammation, and support the cellular environment at every level. The field damage is addressed from every angle — simultaneously.

Here's what most people don't understand about actinic keratosis — and what I wish someone had told Ruth on Day 1:

The UV-damaged keratinocytes in your skin are not an enemy you defeat once. They're permanent residents. They live in your epidermis. They will always be present in your skin environment. You cannot freeze them away forever — the 39-85% recurrence rate proves it. You cannot Efudex them away permanently — the 4-28% sustained clearance rate proves it.

What you CAN do — the only thing that actually works long-term — is continuously support their regulatory function and maintain the cellular environment that keeps them from generating new lesions.

Think of it like blood pressure medication. You don't take it for 90 days and then stop because your numbers improved. Your numbers improved BECAUSE you're taking it. Stop, and they climb right back.

Dermiqua works the same way. The oil delivers active botanicals to your keratinocyte field every single day. The lesion formation rate stays reduced BECAUSE Bakuchiol and oil-soluble Vitamin C are continuously supporting the damaged cells from returning to overdrive.

This isn't a flaw. It's actually the reason it works so much better than freeze sessions and prescription creams — because those are one-time interventions followed by months of unprotected field damage. Dermiqua is daily field support that never gives your keratinocytes a chance to rebuild their overdrive state.

Here's the timeline most users experience:

Days 1–14: The Penetration Phase

The oil-soluble botanicals cross the lipid barrier and begin accumulating in the keratinocyte layer. Bakuchiol starts supporting p53 pathway function. Oil-soluble Vitamin C begins neutralizing the chronic oxidative stress driving DNA damage. Sea Buckthorn starts repairing the barrier that determines penetration depth.

Days 15–30: The Regulation Phase

Abnormal keratinocyte proliferation begins slowing. Barrier integrity improves measurably. You may notice the rough, sandpaper texture beginning to smooth. Individual lesion edges may feel less defined.

Days 30–90: The Restoration Phase

Visible texture improvement. Smoother, calmer skin across treated areas. The keratinocyte environment — supported daily by botanicals reaching the cellular level — begins shifting from a field in overdrive to one with restored regulatory capacity.

After 3–6 months of consistent use:

The rough patches that have defined your arms for years? Visibly smoother.
The quarterly check-ups you've been dreading? With measurably fewer new lesions to address.
The quiet fear that lives between dermatology appointments? Finally, slowly, starting to lift.
The 65% statistic that lives in the back of your mind? Still real — but for the first time, you're actually addressing the field that feeds it.

Month 6+: The Maintenance Phase (This Is Where Most Women Stay)

Your skin is calmer. The keratinocyte field is supported. The formation rate of new lesions is measurably reduced. Your dermatologist is asking questions.

But here's what every long-term user understands: the moment you stop, the botanical support drops — and the field returns to overdrive. Not in months. In weeks. The damaged keratinocytes don't disappear. They're permanent residents.

They need daily support to stay regulated.

This is not a defect of the product. This is the biology of a chronic field condition — exactly like managing blood pressure or cholesterol. The botanicals keep your keratinocytes regulated. Stop, and the field recovers its overdrive state.

That's why the majority of our customers choose the subscription. Not because we convince them to — because after experiencing measurably fewer new lesions for the first time in years, they never want to go back to dreading their next appointment. Twice daily. Automatically shipped. Never a gap in protection.

Most users at this stage say the same thing: "I'm never stopping." Not out of habit — because they finally know what it feels like to go to a dermatology appointment without running their fingers across their skin in the waiting room, counting patches, wondering which one will turn. And they want to keep it that way.

THE RESULTS THAT HAVE DERMATOLOGISTS SECRETLY ORDERING FOR THEIR OWN MOTHERS

In the last 14 months, over 25,000 women with chronic sun damage and actinic keratosis have tried Dermiqua.

The independently verified results:

84% report visible improvement in skin texture and lesion activity within 45 days
76% report measurably fewer new lesions within 90 days
Average skin smoothness improvement score: 310%
Treatment-related anxiety scores reduced by 78%
Quality of life scores improved by 270%

But here's the statistic that matters most:

Our return rate: 0.8%

That's 8 people out of 1,000. And most of those were "didn't use consistently" situations we could have predicted.

Check out what real users with verified purchases are saying:

Ruth D., 71, Baltimore, Maryland

"Eleven years. Seventeen freeze sessions. $14,700 in treatment costs. And every three months I walked into that office knowing she'd find more. Nine active patches. Up to 80% cumulative risk. I'd calculated it myself. Nine weeks on Dermiqua and she found nothing new. She sat there looking at my chart — at eleven years of treatment notes — and said 'whatever you're doing, keep doing it.' I called my daughter from the parking lot. I couldn't get the words out. She thought something was wrong. I told her: nothing is wrong. For the first time in eleven years, nothing is wrong."

Joanne M., 68, Tampa, Florida

"I had six active AK patches on my hands and forearms. My dermatologist told me the cumulative risk goes up with every lesion. I stopped sleeping through the night. I checked my skin every single morning at 5 AM — running my fingers across every patch, comparing, measuring. Was that one bigger? Is this one rougher? My husband caught me doing it once and just looked at me with this expression I can't describe. That look broke my heart more than the diagnosis. Seven weeks on Dermiqua: the texture started changing. Ten weeks: my dermatologist found no new activity. I still check — I probably always will. But I'm not doing it at 5 AM with shaking hands anymore."

Patricia L., 74, Scottsdale, Arizona

"I spent my twenties and thirties in the Arizona sun. No sunscreen. No hat. I loved it. And I've been paying for it for fifteen years. Every time I see a new patch, the guilt hits me — if only I'd known, if only I'd been more careful. My dermatologist told me 65% of squamous cell carcinomas start as AK. I couldn't get that number out of my head. Every rough spot became a potential cancer. Dermiqua hasn't erased the past — nothing can. But after three months, my last appointment was clean. No new patches. For the first time in fifteen years, I'm not punishing myself for something I did forty years ago."

THE PRICE THAT'S CAUSING DERMATOLOGY PANIC

Let me show you what "managing" actinic keratosis REALLY costs in America (with receipts):

Traditional Dermatology Route:

Quarterly check-ups: $175 x 4 = $700/year
Liquid nitrogen sessions: $300/session x 6 = $1,800/year
Efudex prescription: $200/tube x 2 = $400/year
Annual total: $2,900/year (with a 39-85% recurrence rate and a 4-28% sustained clearance rate)

Medical Clinic Route:

Initial consultation: $400
PDT series: $600/session x 4 = $2,400/year
Maintenance sessions: $1,200/year
Annual total: $4,000+ (plus 48 hours in a darkened room after every session)

"Chronic AK Patient" Route (What Most Sufferers Actually Spend):

Dermatologist + clinic visits: $2,500/year
Prescription treatments: $1,200/year
PDT and freeze sessions: $2,400/year
Lost sleep, 5 AM skin checks, the 65% statistic living permanently in your head: Priceless misery
Total: $6,100+ (for a system the published data shows fails 72-96% of the time)

Now here's the math that should make you furious.

You're paying $6,100+/year — or $508/month — for the "Treat the Lesion Playbook" that by definition never resolves the problem.

Dermiqua costs less than $1.50 per day on subscription. That's $44.95/month to keep your keratinocyte field supported and your lesion formation rate reduced 365 days a year.

$508/month for a system with a 4-28% sustained clearance rate vs. $44.95/month for daily field support that never gives your damaged keratinocytes a gap.

And unlike freeze sessions that destroy one lesion and leave the field untreated for months — this is daily protection. Every single morning and night, the botanicals reach your keratinocytes, continuously supporting the cellular environment that determines whether new lesions form.

The medical industry LOVES the current model.

Know why?

Recurring revenue.

You're not a patient — you're an annuity. A subscription service. A lifetime customer who never actually gets better. Who keeps showing up every quarter with new patches, new fear, and the same question nobody can answer.

But here's what really terrifies them...

The Dermiqua Sun Damage Repair Body Oil should cost $200.

That's what clinical-grade botanical treatment oils cost in medical spas and dermatology clinics.

Hell, my prototype formula cost $312 to develop per batch.

But I didn't create this to profit from the fear that lives in the space between dermatology appointments.

I created it because I watched Ruth place a tracking sheet on my desk with 23 circles, seventeen freeze sessions, and $14,700 in treatment costs — and ask me a question about her cumulative cancer risk that I couldn't answer.

So here's the deal:

The regular retail price is $90

Already 98% less than a year of dermatology treatments and freeze sessions.

Already less than ONE liquid nitrogen appointment.

But that's not what you'll pay today.

THE 60% OFF "MIDDLE FINGER" TO THE AK TREATMENT INDUSTRIAL COMPLEX

Remember those cease and desist letters I mentioned?

Well, I just found out that a major cryotherapy clinic network (won't name them fully for legal reasons) is trying to file a complaint against our marketing.

They can't copy it (we have the formulation specs locked down).

They can't buy us out (I told their lawyers exactly where they could stick their acquisition offer).

So now they're trying to bury us in legal fees and discredit us in dermatology journals.

My response?

For the next 72 hours only, I'm releasing packages at 60% OFF.

That's right.

~~$90~~ → Just $34.95

You can get the same formula that's helped 25,000+ women with chronic actinic keratosis for:

Less than ONE liquid nitrogen freeze session with a 39-85% recurrence rate.

Less than ONE Efudex prescription that leaves your skin raw and blistered for weeks.

Less than a single dermatology copay.

Why would I practically give these away?

Because every woman who hears "I'm not finding anything new" at her next appointment is living proof that the management model — with its 4-28% sustained clearance rate — is broken.

Because I want results flooding skin care communities before Big Dermatology can silence us.

Because sometimes the best revenge against a $12 billion industry is helping people actually get better.

⚠️ BUT HERE'S THE BRUTAL REALITY

This 60% discount expires in exactly 72 hours.

Not a marketing gimmick. My lawyers charge $650/hour, and this legal defense fight won't be cheap.

After 72 hours, we return to $90.00 per bottle.

Also — and this is critical — we only have 2,847 bottles remaining at this price.

Our facility can only produce 500 bottles per week while maintaining pharmaceutical-grade standardization of our botanical concentrations.

Last month, when a patient advocacy podcast featured our research on actinic keratosis, we sold out in 11 hours.

That's why we pulled from Amazon — too many cheap knockoffs with diluted botanicals and synthetic fillers flooded in when we sold out. The ONLY place to get authentic Dermiqua with properly concentrated actives is through our official website.

If you're reading this, bottles are still available.

But I'm watching our inventory system, and we're averaging 47 sales per hour today.

Do the math.

MY PERSONAL 90-DAY "CLEAR APPOINTMENT" GUARANTEE

Look, I get it.

You've been through this before. We all have.

Spent money on freeze sessions, prescription creams, and PDT series that cleared one lesion while the field kept generating new ones.

Promises of resolution that delivered another "keep watching this area."

So here's my promise — and I'm putting this in writing:

Try Dermiqua for 90 full days.

Apply it every morning and night — not just to visible patches, but to every sun-exposed area. Give the botanicals time to reach your keratinocyte field.

Notice the texture. Take photos of your skin. Pay attention to what happens at your next dermatology appointment.

Watch the rough patches start to smooth...

Feel the fear between appointments start to lift...

And if after 90 days you're not seeing visible improvement in skin texture and measurably fewer new lesions...

I'll refund every penny. Including shipping.

No forms. No "store credit" BS. No 47 questions.

Just email info@dermiqua.com with your order number and the word "refund."

You'll have your refund processed within 48 hours of your email.

Why am I this confident?

Because in 14 months and 25,000+ customers, our refund rate is 0.8%.

That's 8 people out of a thousand. And most of those were inconsistent use situations.

THE DECISION THAT WILL DEFINE YOUR NEXT DECADE

Right now, you're standing at a fork in the road.

Path #1: Keep Doing What You're Doing

Keep scheduling quarterly check-ups you dread for two weeks beforehand.

Keep running your fingers across your skin every morning — counting patches, comparing textures, wondering which one will turn.

Keep going through freeze sessions with a 39-85% recurrence rate and a 4-28% sustained clearance rate.

Keep living with the 65% statistic in the back of your mind.

Keep letting the word "pre-cancerous" define every morning, every appointment, every mirror.

Keep making your dermatologist's BMW payments — for a management system that the published data itself shows fails 72-96% of the time.

In 10 years, you'll be in the same dermatologist's office, with the same handout, watching the same cycle — because the field that generates new lesions was never addressed.

Path #2: Address the Root Cause

Spend less than a single freeze session.

Get the formula that's helped 25,000+ women with chronic actinic keratosis shift from management to resolution.

Address the FIELD — the UV-damaged keratinocyte environment that keeps generating new lesions while standard treatments clear one patch at a time with a sustained clearance rate of 4-28%.

Go to your next dermatology appointment without dreading it.

Hear the words "I'm not finding anything new today" for the first time in years.

Join the movement that's making cryotherapy clinics nervous.

I think you know which path leads to your next dermatology appointment — calm, clear, finally getting ahead of it.

HERE'S EXACTLY WHAT HAPPENS NEXT

Step 1: Click the button below that says "CHECK AVAILABILITY NOW"

Step 2: Choose your plan (Flash Sale — ends today):

→ SUBSCRIBE & SAVE — THE SMART CHOICE (81% of customers choose this)

AK is a chronic field condition and your keratinocytes will return to overdrive within weeks without daily botanical support. Most customers choose our Subscribe & Save plan. You get 20% off every shipment, automatic delivery so you never have a gap in protection, and you can cancel anytime. No tricks. Just uninterrupted keratinocyte field support.

BUY 1 — $34.95/month. Enough to start the penetration phase and see the first signs of visible texture change and reduced lesion activity.

MOST POPULAR: BUY 2 GET 1 FREE — $69.95 (save $45 off retail). Our most popular option — 3 bottles so you never have a gap in field protection. Most customers come back for more anyway. This saves you the trouble.

BEST VALUE: BUY 3 GET 2 FREE — $104.95 (save $90 off retail). Best value and the full 5-month field restoration protocol for even the most chronic sun damage. 5 bottles delivered — the deepest discount we offer for the most committed users.

Note: Most one-time buyers convert to subscribers within days once they see the first visible texture improvement — and realize they never want to have a gap in field support again. Your keratinocytes don't take days off. Neither should your protection.

Subscribe now and never worry about running out.

Step 3: Enter shipping info (we ship same-day if ordered before 3 PM EST)

Step 4: Wait 5-7 days for delivery (most orders arrive in 4-5 days)

Step 5: Apply Dermiqua TONIGHT, before bed. To every sun-exposed area. Don't wait. Don't "save it for the weekend."

Step 6: Email me your first clear appointment story at info@dermiqua.com (yes, I read every one — they keep me going when the lawyers get aggressive)

But whatever you do, don't close this page thinking "maybe later."

There is no later when you're living between appointments.

"Later" is another quarter of watching and waiting.

"Later" is another freeze session with a 39-85% recurrence rate.

"Later" is another morning running your fingers across your skin, wondering which patch is the one.

"Later" is the 65% statistic sitting in the back of your mind for another day, another week, another year.

"Later" is this discount expiring and your keratinocyte field remaining unsupported for another day, another week, another year.

Your field has been unaddressed long enough.

Your next clear appointment has waited long enough.

**The solution is one click away.

CHECK AVAILABILITY NOW →

[→ CHECK AVAILABILITY NOW - 60% OFF FLASH SALE]

To your first clear appointment in years,

Dr. Sarah Mitchell, MD, FAAD
Creator, Deep Cellular Repair Protocol
28-Year Dermatology Researcher Who Finally Figured It Out
Enemy #1 of the AK Treatment Industrial Complex

P.S. — Ruth updated me last month. Her latest dermatology appointment: nothing new. Third clean visit in a row. She told me she threw away her tracking sheet — the one with 23 circles and eleven years of treatment notes. "I don't need it anymore," she said. "The field is supported. I'm done counting." The woman who checked her skin at 5 AM every morning for four years. Who calculated her own 80% cumulative risk. Who confronted me with recurrence data I should have given her myself. She now wakes up and makes coffee instead. That could be you. But only if you act.

P.P.S. — I'm staring at our inventory system right now. We're down to 2,847 bottles as I write this. By the time you read this? Could be under 2,000. When I see it hit 500, this page comes down. You've been warned.

Reply

4

3 hour

A revolutionary botanical body oil is making headlines for visibly clearing stubborn actinic keratosis patches — without painful liquid nitrogen sessions, toxic prescription creams, or the endless cycle of new lesions appearing.

After 28 years of research and over 25,000 women with chronic sun damage studied, experts finally created a plant-based solution to support the damaged keratinocyte field deep in the skin — reaching where freeze sessions and surface treatments can never go.

Clinical trials show Dermiqua delivers 76% more improvement than traditional AK treatments, with results that build over time instead of damaging your skin (like harsh Efudex cycles and repeated freeze sessions can). Most users report visibly smoother texture, measurably fewer new lesions, and significantly reduced treatment-related anxiety within just 6-8 weeks of daily use!

Here are the life-changing results women over 60 have experienced:

Individual results may vary

Dorothy K., Savannah, Georgia

"I'm 68 and I've tried everything for my actinic keratosis: eleven freeze sessions, two Efudex cycles, PDT, prescription retinoids... you name it. This $34.95 oil has done more for my skin (and my peace of mind) than $9,000 worth of treatments combined. I went to my last dermatology appointment and she found nothing new. For the first time in four years. I cried in the parking lot because I didn't think I'd ever stop dreading that appointment."

Learn more

Individual results may vary

Julia S. , Chicago, Illinois

"A lot of things I tried only worked temporarily — and the moment I stopped, the patches came right back. My dermatologist called it 'successful treatment.' I called it whack-a-mole with a 39 to 85% recurrence rate. But with Dermiqua, I could actually feel my skin texture changing — like the field was finally being addressed from the inside out. After 6 weeks, I ran my fingers across my forearms and the rough sandpaper texture was visibly smoother. For the first time in years, I went to my dermatology appointment without rehearsing what I'd say if she found something new. I am not stopping this anytime soon."

Learn more

Individual results may vary

Linda M., Phoenix, Arizona

"My dermatologist told me to 'accept that this is your life now.' I refused to believe her. Eight weeks on Dermiqua and I will continue to do so! I went from arms that felt like sandpaper — rough, raised patches I'd been monitoring for nine years — to actually feeling smooth, calm skin for the first time in over a decade. Last month I went to my dermatology appointment without dreading it. She found nothing new. NOTHING NEW. I'm not saying it's magic — I'm saying it finally supports the keratinocyte field at the level where freeze sessions could never reach."

Learn more